CMEA CAPITAL

cmea-capital-logo

CMEA closed in April of 2015 and has unveiled its new corporate identity as [Presidio Partners](https://www.crunchbase.com/organization/presidio-partners). CMEA Capital is a venture capital firm with a clear focus on life sciences, high technology, and energy and materials investments. We believe that the most successful venture backed companies are those that are science based, with experienced teams that have a vision. As a result, CMEA typically invests in companies that have cutting edge an... d highly differentiated technology at their core and founding teams of the highest caliber still in place. These are companies that have the potential to transform their industries. CMEA Capital was founded in 1989 and maintains offices in San Francisco and Menlo Park. We invest in both early and late stage science-focused ventures, and leverage a strong network of corporate, investment, and entrepreneurial relationships on behalf of portfolio companies. Our partners and associates have extensive science, engineering, and operational backgrounds, providing us the confidence to look beyond today's technology. We apply our focus on science and teams to our collaborations with entrepreneurs and venture investment partners who are changing the world, one great company at a time.

#People #Financial #More

CMEA CAPITAL

Social Links:

Industry:
Banking Finance Venture Capital

Founded:
1989-01-01

Status:
Closed

Technology used in webpage:
Apple Whitelist


Founder


tom-baruch_image

Tom Baruch

Investments List

Date Company Article Money raised
2015-05-01 VYNE Therapeutics CMEA Capital investment in Series A - VYNE Therapeutics 14.3 M USD
2015-04-20 Cnano Technology CMEA Capital investment in Series B - Cnano Technology 15 M USD
2014-10-07 Jobvite CMEA Capital investment in Series D - Jobvite 25 M USD
2014-05-15 Sorbent Therapeutics CMEA Capital investment in Series D - Sorbent Therapeutics 6.5 M USD
2014-05-08 Arcadia Biosciences CMEA Capital investment in Series D - Arcadia Biosciences 33 M USD
2014-03-04 Neos Therapeutics CMEA Capital investment in Series C - Neos Therapeutics 15.5 M USD
2014-01-08 Auspex Pharmaceuticals CMEA Capital investment in Series E - Auspex Pharmaceuticals 20 M USD
2013-11-04 MediaSpike CMEA Capital investment in Series A - MediaSpike 5.2 M USD
2013-07-15 Mojo Networks CMEA Capital investment in Series D - Mojo Networks 10 M USD
2013-04-01 Spitfire Pharma CMEA Capital investment in Venture Round - Spitfire Pharma 500 K USD

More informations about "CMEA Capital" on Search Engine